Related Experiment Videos
Case-crossover and case-time-control designs in birth defects epidemiology.
Sonia Hernández-Díaz1, Miguel A Hernán, Katie Meyer
1Slone Epidemiology Center, Boston University School of Public Health, 1010 Commonwealth Avenue, Boston, MA 02215, USA. shernan@bu.edu
American Journal of Epidemiology
|August 14, 2003
Summary
Case-crossover and case-time-control designs were evaluated for birth defects epidemiology. These methods did not show clear advantages over traditional case-control studies when accounting for exposure time trends.
Area of Science:
- Epidemiology
- Birth Defects Research
- Study Design Methodology
Background:
- Case-crossover and case-time-control designs are used for intermittent exposures and acute events.
- Birth defects epidemiology often involves complex exposure timing.
- Traditional case-control studies are common but may have limitations.
Purpose of the Study:
- To compare the utility of case-crossover and case-time-control designs against traditional case-control studies in birth defects epidemiology.
- To evaluate the association between folic acid antagonist use and cardiovascular defects using different study designs.
Main Methods:
- A case-control study compared folic acid antagonist use in the second and third pregnancy months with cardiovascular defects.
- A case-crossover design compared exposure during a sensitive period versus a prior control period.
- A case-time-control design adjusted for exposure time trends.
Main Results:
- The case-control study found an odds ratio of 2.3 (95% CI: 1.4, 3.9) for folic acid antagonist use and cardiovascular defects.
- The case-crossover design yielded an odds ratio of 1.0 (95% CI: 0.5, 2.0).
- The case-time-control design resulted in an odds ratio of 2.9 (95% CI: 1.2, 7.2).
Conclusions:
- Case-crossover and case-time-control designs may be biased by time trends in exposure prevalence.
- When gestational time trends of exposure are present, these newer designs may not offer clear advantages over the case-control design.
- Careful consideration of study design is crucial in birth defects epidemiology, especially concerning exposure timing.